) We must remind you that the reductions in bacteria-moulds-VOC-viruses may vary from those indicated based on the characteristics of the environment and its use (size, presence density, ventilation, basic hygienic conditions). The virucidal activity was tested using the SARS - CoV-2 (Covid-19) strain. All experiments were conducted in a Biosafety Level 3 Laboratory (BSL3). The use of Jonix devices DOES NOT exclude compliance with the provisions for the prevention and containment of the pandemic. JONIX vmc 4people NON THERMAL PLASMA TECHNOLOGY CONTROLLED MECHANICAL VENTILATION UNIT WITH HEAT RECOVERY AND SANITISATION FOR CEILING INSTALLATION by the University of Padua Bacteria, Moulds, VOCs and Viruses virus multidrug-resistant bacteria

multidrug-resistant bacteria Bacterial and chemical pollutants develop inside air distribution systems and are transported by the airflow to the rooms. Jonix vmc 4people with cold plasma technology eliminates bacteria, viruses, moulds, chemical pollutants, VOC and odours ensuring bacterial decontamination of the ducts’ internal surfaces as well as of the air that flows through. Jonix vmc 4people is a controlled mechanical ventilation system for the continuous exchange of ambient air without the need to open windows which, thanks to the integration with cold plasma technology, eliminates bacteria,...

AIR PURIFICATION AND SANITISATION DEVICE Sanitization system of the air out with advanced cold plasma technology Patented active sanitizing system of internal components with advanced cold plasma technology Patented active sanitizing system of internal components with advanced cold plasma technology JONIX vmc 4people basic JONIX vmc 4people plus The devices of Jonix vmc 4people line (basic and plus versions) are controlled mechanical ventilation units, with heat recovery and sanitisation with cold plasma technology, for the purification and decontamination of the air and the surfaces of the room...

multidrug-resistant bacteria EFFICIENCY The bio acid and neutralization activity of polluting substances occurs quickly and continuously. The continuous functioning of the device blocks the spreading of bio hazardous agents generated on a continuous basis during the activities. Jonix vmc 4people with NTP technology is efficient on: gram + and – bacteria, yeast and mould, virus, bacterial endotoxines, VOC (volatile organic compound), odours. The reactive species generated by NTP technology, including reactive oxygen species, have a high oxidising power and act on various components. They react...

APPLICATION SECTORS * The Jonix vmc 4people device is suitable for environments in which it is necessary to reduce air contamination in places with a high concentration of people and in transit areas, but, due to its compact shape and its sanitising action, it can be used in numerous other smaller environments such as offices, medical, dental and veterinary practices, classrooms, professional kitchens, canteens, warehouses, etc. *) We must remind you that the reductions in bacteria-moulds-VOC-viruses may vary from those indicated based on the characteristics of the environment and its use (size,...

multidrug-resistant bacteria TECHNICAL FEATURES JONIX vmc 4people Models 1 standard ambient NTP generator 1 ambient NTP generator or 2 ambient NTP generators on request Jonix vmc 4people with cold-plasma technology eliminates bacteria, moulds, viruses, chemical pollutants, VOCs and odours ensuring bacterial decontamination of the internal surfaces of the ducts and the air in the environment. Non Thermal Plasma (NTP) Generators Generators replacement Generators Maintenance Air inlet pre-filter renewal Air inlet filtration type renewal F7 – Fine dust filter EN 779-201 Type of filtration exhausted...

Hallmark for health and living comfort in confined spaces (UNI EN 16000- UNI EN14 412). Validated product Reference standards NATIONAL LAWS AND STANDARDS Valid for the following categories: Civil, Industrial, and Healthcare sectors Italian Legislative Decree 81/2008 Consolidated Law on Health and Safety in the Workplace of 10th April 2008 (published in the Ordinary Supplement No. 108 of the Offical Gazette No. 101 of 30th April 20081; Legislative Decree No. 81 was published on 9th April 2008) • Guidelines issued by the Italian Presidency of the Council of Ministers (Permanent Conference for relations...

multidrug-resistant bacteria Benefit Corporation [email protected] [email protected] Registered Office Operational Headquarters Via dell’Artigianato, 1 35020 San Pietro Viminario (PD) – Italy Ph. +39 0429 760311 Research and Development Headquarters Via Tegulaia 10/b 56121 Pisa - Italy Ph. +39 050 985165